RenalSense

RenalSense is a medical device company dedicated to real-time renal diagnostics. The companys first-of-its-kind product, Clarity RMS, changes the practice of ICU and critical care management by providing continuous monitoring of urine flow for real-time assessment of renal function and early detection and prevention of ICU-acquired Acute Kidney Injury (AKI). AKI - Current Medical Practice Over 30% of critical care patients develop AKI, requiring an average three additional hospital days and $7,500 of additional hospital costs per patient. Mortality rates remain staggeringly high, approaching 83% in those patients with AKI requiring dialysis. Current medical practice in the ICU is to...

Early detection and prevention of acute kidneys injury,icu cost saving.,icu aki screening,fluid management,nephrology,urine output,and aki

Renalsense operates in the Medical equipment manufacturing industry.

Renalsense's revenue is 11m - 100m

Renalsense has 11 - 50 employees.